EP2493466
NOVEL ANTITUMORAL USE OF CABAZITAXEL
Anmelder
AVENTIS PHARMA SA [FR]SANOFI MATURE IP [FR]
Erfinder
GUPTA SUNIL [US]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 31/164A61K 31/56A61K 45/06A61P 35/00
CPC-Klassen
A61K 31/164A61K 31/337A61K 31/56A61K 31/573A61K 38/193A61K 45/06A61P 13/08A61P 15/00A61P 25/16A61P 35/00A61P 35/04A61P 43/00
AI: Life Sciences
warum
Sanofi/Aventis pharma — A61K + A61P35. Life Science.